AYTU
NASDAQ · Pharmaceuticals
Aytu Biopharma Inc
$2.68
+0.03 (+1.13%)
Open$2.68
Previous Close$2.65
Day High$2.69
Day Low$2.65
52W High$3.07
52W Low$0.95
Volume—
Avg Volume45.5K
Market Cap27.80M
P/E Ratio—
EPS$-3.39
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+241.4% upside
Current
$2.68
$2.68
Target
$9.15
$9.15
$5.34
$9.15 avg
$10.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 113.02M | 128.13M | 4.25M |
| Net Income | -23,090,282 | -23,558,841 | 1.24M |
| Profit Margin | -20.4% | -19.4% | 29.2% |
| EBITDA | -7,055,601 | -7,598,708 | 1.93M |
| Free Cash Flow | — | — | 869.5K |
| Rev Growth | -11.8% | -11.8% | +20.1% |
| Debt/Equity | 1.15 | 1.15 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |